Europe Respiratory Care Device Market

The report "Europe Respiratory Care Device Market Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings)- Regional Forecast to 2031", is projected to grow from USD 6.33 billion in 2026 and to reach USD 8.96 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period.

Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Europe Respiratory Care Device Market Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings)- Regional Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-respiratory-care-devices-market-7779229.html

Rising respiratory diseases in the region, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, are among the major drivers of growth in the European market for respiratory care devices. Some factors include an aging population, continued smoking, and exposure to air pollution in many European countries. Older people being more vulnerable to respiratory diseases is therefore one of the reasons the demand for ventilators, oxygen therapy systems, and respiratory monitoring devices remains high. Besides that, the rapidly advancing technology in portable oxygen concentrators, smart inhalers, and digitally connected ventilators is not only increasing treatment efficiency but also patient compliance, resulting in greater use of these devices in hospitals and homes. The present trend of home healthcare and remote patient monitoring is also making devices that are used outside traditional clinical settings more and more popular. In addition to this, a strong healthcare system in Europe, good reimbursement schemes in some countries, increased awareness of respiratory issues after the pandemic, and a focus on the management of chronic diseases are, among other things, points that help the development of advanced respiratory care technologies to continue, and also the usage of these new technologies.

Therapeutic respiratory care devices accounted for the largest share by product in the European respiratory care devices market in 2025.

In the European market of respiratory care devices, the therapeutic respiratory care devices segment has the largest share among the product categories because the treatment and management of respiratory diseases, which are very common, e.g., chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and sleep apnea, revolves around these devices. Equipment such as ventilators, oxygen therapy devices, nebulizers, and CPAP/BiPAP systems is essential not only in emergencies, such as hospitals and intensive care units, but also in long-term care, particularly in home healthcare. Demographic change, which is causing an aging population, together with the rise of chronic respiratory diseases in Europe, has made people more dependent on these therapeutic solutions for the regular management of their disease and respiratory assistance. Furthermore, the preference for home care has led to a demand for portable and easy-to-use devices. In contrast, technological innovations, e.g., miniaturized oxygen concentrators and digitally controlled ventilators, have further made their usage more convenient. Therefore, therapeutic respiratory care devices remain the leading product segment, as they are clinically necessary for improving patient outcomes and reducing burden on hospital systems.

The hospitals segment accounted for the largest share of the Europe respiratory care devices market by end user in 2025.

The segment of hospitals ends users in the Europe respiratory care market has the biggest share. This is because hospitals are the main centers for diagnosis, acute treatment, and long-term management of serious respiratory conditions such as COPD, pneumonia, ARDS, and sleep-related breathing disorders. Hospitals experience a high volume of respiratory emergencies and very sick patients, which drives strong demand for ventilators, oxygen delivery systems, nebulizers, and advanced respiratory monitoring devices in intensive care units, operating rooms, and emergency departments. The presence of specialized respiratory care professionals and cutting-edge infrastructure is an additional factors that lead to greater device utilization in hospital settings. Moreover, post, COVID preparedness has encouraged numerous hospitals in Europe to enhance their critical care facilities and purchase state, of, the, art respiratory equipment. In general, the growing number of hospital admissions for respiratory diseases, coupled with ongoing hospital technology upgrades and adherence to strict regulatory requirements, has made hospitals the primary end-user segment in the European respiratory care devices market.

In 2025, Germany accounted for the largest share of the Europe respiratory care devices market.

Germany had the largest share of the European respiratory care devices market due to its robust healthcare system, high healthcare spending, and a large number of patients with chronic respiratory diseases such as COPD, asthma, and sleep apnea. The country has a highly efficient hospital network and a large number of intensive care units. This scenario creates a high demand for ventilators, oxygen therapy systems, and sophisticated respiratory monitoring devices. Besides, the German population, which is getting older, has a higher incidence of respiratory disorders, thus requiring support from therapeutic and diagnostic respiratory equipment. Strong reimbursement schemes and the rapid adoption of high-tech medical devices are among the reasons driving market expansion. Moreover, Germany is home to the world's foremost medical device manufacturers. It focuses on clinical innovation and quality standards, which have facilitated early adoption of advanced respiratory care technologies. This capability has helped the country to keep its leading position in the European respiratory care devices market.

Key Market Players

The key players in the Europe respiratory care devices market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (US), Masimo (US), and among other players.

Don’t miss out on business opportunities in Europe Respiratory Care Device Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/